Availability of Lenzetto (estradiol spray) allows the NHS to offer an alternative transdermal hormone replacement therapy (HRT) to eligible women experiencing the menopause, offering more options to ...

Vivius has received FDA approval for the marketing of Evamist, a metered dose transdermal estradiol spray for the treatment of moderate to severe vasomotor symptoms due to menopause. Evamist is the ...

Overview: Transdermal estradiol is available as a patch, gel, or spray that is applied to the skin to increase estrogen levels. It is used after menopause to prevent osteoporosis or to reduce vaginal ...

The optimal treatment for menopausal hot flashes is estrogen therapy. 4 Estrogen replacement results in a markedly greater reduction in the frequency and severity of hot flashes than placebo, as ...

WASHINGTON (CBS.MW) -- Vivus shares jumped more than 7 percent Tuesday after the Mountain View, Calif.-based firm announced it had completed a Phase 2 study of Testosterone MDTS to treat female sexual ...

Estradiol 1.53 mg/spray; transdermal spray. The addition of exogenous estrogens helps to alleviate the vasomotor symptoms that are associated with declining estrogen levels.Evamist is designed to ...

OTTAWA, ONTARIO--(Marketwired - March 30, 2017) - CannaRoyalty Corp. (CSE:CRZ)(CNNRF) ("CannaRoyalty" or the "Company") is pleased to announce it has signed a binding term sheet giving CannaRoyalty ...

The Population Council (New York, NY) and Acrux Pharmaceuticals (West Melbourne, Australia) have reported positive Phase I results for the first contraceptive spray for women. Results indicate that ...